Agree with everything in your post but historically they had a lot of trouble relying on consistent sales, it was either feast or famine.
My view is that the health and value of the business long term will be more aligned to the strength and growth of those underlying, recurring metrics.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities Report - 31 Dec 2021
SP3
spectur limited
Add to My Watchlist
0.00%
!
1.3¢

Agree with everything in your post but historically they had a...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.005M |
Open | High | Low | Value | Volume |
1.3¢ | 1.3¢ | 1.3¢ | $2.959K | 227.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 685321 | 1.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.3¢ | 259984 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 685321 | 0.012 |
5 | 1458551 | 0.011 |
4 | 3250000 | 0.010 |
2 | 350000 | 0.009 |
1 | 150000 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.013 | 259984 | 1 |
0.015 | 450000 | 1 |
0.016 | 3000 | 1 |
0.018 | 120000 | 1 |
0.019 | 347549 | 1 |
Last trade - 14.13pm 04/07/2025 (20 minute delay) ? |
Featured News
SP3 (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online